Category: Regions

March 4, 2021 Off

Nanobiotix, PharmaEngine conclude collaboration

By Dino Mustafić

NANOBIOTIX,a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that the Company has reached an agreement with PharmaEngine to terminate the License and Collaboration agreement that the Company and PharmaEngine entered into in August 2012.

February 15, 2021 Off

Basilea divests its Chinese R&D subsidiary to PHT International

By Dino Mustafić

Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into an agreement to divest its Chinese research and development (R&D) subsidiary Basilea Pharmaceutica China Ltd. (“BPC”), by selling BPC’s parent company BPh Investitionen Ltd. to the U.S.-based custom manufacturing organization PHT International Inc. (“PHT”).

February 3, 2021 Off

BMS sells its Swiss-based factory to WuXi STA

By Dino Mustafić

WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland. The Couvet site will be the first facility in Europe for WuXi STA, a leading Contract Development and Manufacturing Organization. The acquisition will enhance WuXi STA’s existing capabilities while growing capacity to support its partners’ life-saving work.

January 28, 2021 Off

Moderna confirms talking with the US on 100M doses of Cov-19 vaccine

By Dino Mustafić

After the US president’s Biden said the US Federal government would buy 100 million doses of the COVID-19 vaccine from Moderna and another 100 million from Pfizer, Moderna today confirmed that it is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021.